Saunders & Walker P.A. Your Source For Accurate Information
Stryker Rejuvenate / revision comparison
With the recent announcement of a $2.47 billion settlement offer from
Johnson & Johnson over its flawed Articular Surface Replacement (ASR)
hip implant, it is important to remember that the ASR, while the most
popular, was only one of many metal-on-metal hip implants on the market.
The Rejuvenate and ABGII hip replacement systems, both made by Stryker,
were recalled in July 2012. More than 30,000 of the Stryker hip systems
have been installed worldwide, 20,000 of them in U.S. patients. The recall
came after the implant was been found to be prone to corrosion, joint
dislocation, and the release of metal ions, which can cause metallosis,
tissue inflammation, necrosis and death. The announcement has since led to
hundreds of lawsuits being filed against Stryker.
DePuy Announces U.S. Settlement Agreement to Compensate ASR™ Hip System Patients Who Had Surgery to Replace Their ASR Hip
WARSAW, IN, November 19, 2013 – DePuy Orthopaedics, Inc. (DePuy) and the Court-appointed committee of lawyers representing ASR™ Hip System plaintiffs today announced a settlement agreement to compensate eligible ASR patients in the United States who had surgery to replace their ASR hip, known as revision surgery, as of August 31, 2013.
“We are committed to the well-being of ASR patients, as demonstrated by the voluntary recall and the program providing support for recall-related care,” said Andrew Ekdahl, Worldwide President, DePuy Synthes Joint Reconstruction. “The U.S. settlement program provides compensation for eligible patients without the delay and uncertainty of protracted litigation. DePuy remains committed to our purpose of advancing innovative treatment options to serve those who need joint replacement surgery.”
Today, Monday November 18, 2013, the federal court docket reflected for the first time that there is a settlement in the Johns & Johnson ASR metal on metal hip implant litigation. The New York Times and Bloomberg Financial News had reported based upon unnamed sources a $4 billion dollar settlement of the 12,000 lawsuits brought against DePuy and Johnson & Johnson for failures of the ASR metal on metal hip implants. There had been no confirmation of any settlement by Johnson & Johnson, DePuy or any of the lawyers negotiating the deal. Further, the court filings had not provided any confirmation of a settlement. However, several scheduled jury trials involving the ASR had recently been settled or postponed leading to speculation that there had been a “stand down” of litigation in anticipation of a settlement.
Johnson & Johnson DePuy ASR Hip Replacement Implant Lawsuit Settlement Signup Information
Visit our main firm website or call us directly for signup information.
http://www.saunderslawyers.com (800) 748 – 7115
Click Here To Contact Us
Johnson & Johnson will pay more than $4 billion to resolve more than 12,000
lawsuits in federal and state courts over defective DePuy ASR hip implants. Once
approved, this settlement will be the largest US settlement of legal claims for a
medical device, dwarfing the 2001 settlement of claims involving defective Sulzer
hip and knee implants that cost $1 billion.